1-8 of 8
Hédia Chagraoui
Close
Sort by
Journal Articles

Impact of Mutant Haemopoietic Transcription Factor GATA1s on Haemopoiesis

Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath, Gaetan Juban, PhD, Nathalie Sakakini, PhD, Kelly Soady, PhD, Hedia Chagraoui, PhD, Bilyana Stoilova, PhD, Catherine Garnett, Ludovic Lhermitte, MD, Elena Karkoulia, PhD, John Strouboulis, PhD, Catherine Porcher, PhD, Irene Roberts, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3798.
https://doi.org/10.1182/blood.V130.Suppl_1.3798.3798
Published: 2017
Journal Articles

SCL/TAL1: a multifaceted regulator from blood development to disease

Catherine Porcher, Hedia Chagraoui, Maiken S. Kristiansen
Journal: Blood
Blood (2017) 129 (15): 2051–2060.
https://doi.org/10.1182/blood-2016-12-754051
Published: 2017
Journal Articles

SCL-mediated regulation of the cell-cycle regulator p21 is critical for murine megakaryopoiesis

Hedia Chagraoui, Mira Kassouf, Sreemoti Banerjee, Nicolas Goardon, Kevin Clark, Ann Atzberger, Andrew C. Pearce, Radek C. Skoda, David J. P. Ferguson, Steve P. Watson, Paresh Vyas, Catherine Porcher
Journal: Blood
Blood (2011) 118 (3): 723–735.
https://doi.org/10.1182/blood-2011-01-328765
Published: 2011
Includes: Supplemental data
Journal Articles

A major role of TGF-β1 in the homing capacities of murine hematopoietic stem cell/progenitors

Claude Capron, Catherine Lacout, Yann Lécluse, Valérie Jalbert, Hédia Chagraoui, Sabine Charrier, Anne Galy, Annelise Bennaceur-Griscelli, Elisabeth Cramer-Bordé, William Vainchenker
Journal: Blood
Blood (2010) 116 (8): 1244–1253.
https://doi.org/10.1182/blood-2009-05-221093
Published: 2010
Includes: Supplemental data
Journal Articles

Differential use of SCL/TAL-1 DNA-binding domain in developmental hematopoiesis

Mira T. Kassouf, Hedia Chagraoui, Paresh Vyas, Catherine Porcher
Journal: Blood
Blood (2008) 112 (4): 1056–1067.
https://doi.org/10.1182/blood-2007-12-128900
Published: 2008
Includes: Supplemental data
Journal Articles

Characterisation of SCL DNA-Binding Functions In Vivo in Haematopoiesis.

Mira Kassouf, Anna Schuh, MD, PhD, Hedia Chagraoui, PhD, Eduardo Anguita, MD, PhD, Doug Higgs, MD, Paresh Vyas, MD, PhD, Catherine Porcher, PhD
Journal: Blood
Blood (2005) 106 (11): 1733.
https://doi.org/10.1182/blood.V106.11.1733.1733
Published: 2005
Journal Articles

Proteasome Inhibitor Bortezomib Can Inhibit Bone Marrow Fibrosis Development in a Murine Model of Myelofibrosis.

Orianne Wagner-Ballon, MD, Thomas Gastinne, MD, Micheline Tulliez, MD, Catherine Lacout, Didier Pisani, PhD, Hedia Chagraoui, PhD, Jean-Luc Villeval, PhD, William Vainchenker, MD, PhD, Stephane Giraudier, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2582.
https://doi.org/10.1182/blood.V106.11.2582.2582
Published: 2005
Journal Articles

Adenoviral Mediated TGF-β1inhibition in a Murine Model of Myelofibrosis Can Prevent and Cure Bone Marrow Fibrosis Development.

Thomas Gastinne, MD, Orianne Wagner-Ballon, MD, Micheline Tulliez, MD, Hedia Chagraoui, PhD, William Vainchenker, MD, PhD, Stephane Giraudier, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 794.
https://doi.org/10.1182/blood.V104.11.794.794
Published: 2004